Position in REGN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$7,982,916
-$1,788,958 QoQ
Shares Held
10,332
-18.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $183,791,137 across 158 Biotechnology names. REGN ranks #2 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,137 | $10,331,595 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
10,332 | $7,982,916 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,647 | $4,846,252 | |
| 4 | INSM |
INSMED Inc
|
27,937 | $4,568,258 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
81,190 | $3,266,273 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
4,862 | $2,545,111 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
76,039 | $2,526,015 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
39,758 | $2,492,826 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,982,916 | 10,332 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $9,771,874 | 12,660 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,654,465 | 11,835 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,779,325 | 12,913 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $7,309,500 | 11,525 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $9,102,152 | 12,778 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,302,661 | 11,703 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,315,499 | 12,669 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,593,164 | 11,006 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $10,266,331 | 11,689 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,366,211 | 10,166 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,091,063 | 8,477 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,397,522 | 7,786 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,421,171 | 17,216 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $11,904,362 | 17,281 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $10,819,452 | 18,303 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $14,221,228 | 20,362 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $15,467,187 | 24,492 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $16,481,472 | 27,234 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $15,177,207 | 27,173 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $13,297,599 | 28,105 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $13,906,321 | 28,785 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $14,807,860 | 26,453 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $18,029,721 | 28,910 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $10,524,602 | 21,554 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||